Join        Login             Stock Quote

Medicis (MRX) Drops After Disclosing Q-Med Suit Related To Valeant (VRX) Merger

 November 09, 2012 01:47 PM

(By Balachander) Medicis Pharmaceutical Corp. (NYSE: MRX) shares are down sharply after disclosing that Q-Med has filed a suit against the company related to Medicis' merger with Valeant Pharmaceuticals International Inc. (NYSE: VRX).

Medicis holds exclusive U.S. and Canadian rights to market certain dermal filler products, including RESTYLANE, RESTYLANE-L, PERLANE, PERLANE-L and RESTYLANE FINE LINES, through certain license and supply agreements with Q-Med.

The lawsuit alleges that Q-Med has the right to withhold consent to a change of control of Medicis that would result in a transfer to Valeant of the exclusive rights to market and sell the dermal filler products.

[Related -Three Stocks Set For FDA News In Early December]

Valeant agreed to acquire Medicis for roughly $2.6 billion or $44.00 per share in cash in September. 

Q-Med alleges that the action is in aid of arbitration to prevent Medicis from transferring such rights to Valeant as a result of the merger. Q-Med seeks a preliminary injunction prohibiting Medicis from transferring its rights to Valeant during the pendency of the arbitration proceedings that Q-Med will bring.

Medicis believes that Q-Med's action is without merit and intends to vigorously defend itself, the company said in a filing with the U.S. Securities and Exchange Commission (SEC).

Medicis shares, which have been trading in the 52-week range of $29.76 to $43.70, fell 4.96 percent or $2.16 to trade at $41.20 on Friday. Valeant shares added 0.39 percent.

iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageThe S&P 500’s Worrisome Downturn In Drawdown

Last Friday I reviewed some of the bearish signals that were casting dark shadows across the US stock read on...

article imageADP: Private-Sector Employment Rises A Solid 200k In September

The pace of growth for private-sector employment picked up in September, according to this morning’s ADP read on...

article imageTreasury Market’s Inflation Expectations Tumble

The odds for a Fed rate hike are falling like a stone, or so it appears based on the implied inflation read on...

article imageEmerging Market Stocks: Last Week’s Red-Ink Leader

Value investors on the lookout for bargains have recently been eyeing up the battered corner of emerging read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.